DeFloria said Monday that the Federal Drug Administration has stamped the firm’s application to begin a Phase 2 clinical trial for AJA001, an oral cannabinoid drug...
Amid fresh uncertainty over federal marijuana rescheduling, cannabis businesses of all sizes face questions around what the best tax strategy may be for the upcoming filing...
This article was reprinted with permission from Crain’s Detroit Business. The city of Detroit, a relatively new entrant into the regulated adult-use recreational market, is set...
Nearly 500 Eaze cannabis workers ratified a new three-year contract with United Food and Commercial Workers Union following months of corporate upheaval and wage rug pulls...
The BC Bud Corp. (CSE: BCBC) announced Friday it plans to transform from a pure cannabis company to an investment firm focused on digital and physical...
Canadian cannabis shops rang up nearly C$500 million in sales last December, capping a year of modest growth for the country’s legal marijuana market. Monthly sales...
The state of Colorado awarded its first-ever psilocybin-related licenses to prospective business owners, kickstarting what could be a major new therapeutic industry, directly in the wake...
Kentucky’s medical cannabis program has hauled in approximately $27.5 million in application fees during its two-month application window, according to state officials. The Cabinet for Health...
Executives at Innovative Industrial Properties Inc. (NYSE: IIPR) sent a blunt message to the company’s cannabis tenants during its fourth-quarter earnings call: Try to skip rent...
The New Jersey Cannabis Regulatory Commission changed up its marijuana testing standards to require much more specific testing and results from licensed cannabis companies. The new...